Genedata, HighRes Biosolutions, and Titian Software announce a partnership integrating their flagship products into a seamless solution that automates iterative drug discovery processes for designing and planning, testing, and data analysis. The approach offers a streamlined workflow from sample logistics to automation to analysis and back, effortlessly moving information to where it is needed and ultimately providing researchers with the time and freedom to focus on their science. This industry-first integration, which brings real-time data analysis and heightening efficiencies to screening labs, will be showcased by the three partners at SLAS2018 (Feb 3-7, San Diego Convention Center).
This partnership brings together best-in-class solutions relied on by the world’s leading pharmaceutical and biopharmaceutical companies and CROs: Titian’s Mosaic sample management software, HighRes’ automation and Genedata Screener. Moreover, it empowers researchers to quickly and easily perform complex informatics workflows, which typically span many departments and informatics resources.
With the solutions’ integration, screening scientists can now design and order assay plates in the Titian Mosaic sample management software, accept and run the fully automated screening process on the HighRes automated system, and trigger the automated data analysis and approval in Genedata Screener. This highly automated workflow allows scientists to step away from tedious manual tasks, decreases the potential for errors, and removes bottlenecks. Delivering a new level of laboratory automation, the integration is inherently flexible and significantly improves the efficiency of research processes while providing a full audit trail for data, samples and operations.
The partners will demonstrate their combined screening solution at the SLAS2018 conference in San Diego. Their tutorial “Partnering to Close the Screening Loop: From Sample Logistics to Automation to Analysis and Back,” will be held on Feb. 6 at 2pm in Room 2.